Journal
MOLECULAR CANCER RESEARCH
Volume 15, Issue 4, Pages 418-428Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-16-0366
Keywords
-
Categories
Funding
- NIH [R01 CA140582]
- Sun Yet-sen University
Ask authors/readers for more resources
14-3-3s has been implicated in the development of chemo and radiation resistance and in poor prognosis of multiple human cancers. While it has been postulated that 14-3-3s contributes to these resistances via inhibiting apoptosis and arresting cells in G2-Mphase of the cell cycle, the molecular basis of this regulation is currently unknown. In this study, we tested the hypothesis that 14-3-3s causes resistance to DNA-damaging treatments by enhancing DNA repair in cells arrested in G2-M phase following DNA-damaging treatments. We showed that 14-3-3s contributed to ionizing radiation (IR) resistance by arresting cancer cells in G2-Mphase following IR and by increasing non-homologous end joining (NHEJ) repair of the IR-induced DNA double strand breaks (DSB). The increased NHEJ repair activity was due to 14-3-3s-mediated upregulation of PARP1 expression that promoted the recruitment of DNA-PKcs to the DNA damage sites for repair of DSBs. On the other hand, the increased G2-M arrest following IR was due to 14-3-3s-induced Chk2 expression. Implications: These findings reveal an important molecular basis of 14-3-3s function in cancer cell resistance to chemo/radiation therapy and in poor prognosis of human cancers. (C) 2017 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available